uniQure N.V. (36) | Collaboration Agreements (3)
Recent Contracts
-
Amendment to Collaboration and License Agreement by and between uniQure Biopharma B.V. and Bristol-Myers Squibb Company dated December 1, 2020
(Filed With SEC on March 1, 2021)
-
Amended and Restated Collaboration Agreement by and between 4D Molecular Therapeutics, Inc and uniQure biopharma B.V., dated August 6, 2019
(Filed With SEC on October 28, 2019)
-
Collaboration and License Agreement by and between 4D Molecular Therapeutics, Inc and uniQure biopharma B.V., dated August 6, 2019
(Filed With SEC on October 28, 2019)
